Clinical Trials on Glabellar Crease

Metastatic Breast Cancer

Eating Behavior | Weight Management | Breast Cancer Survivorship | Mindful Eating Intervention

Breast Cancer Female

Female Breast Cancer

Breast Cancer Female

Peripheral Neuropathy | Breast Cancer Female

Breast Cancer

Early Stage HER2+ Breast Cancer

Metastatic Breast Cancer

Advanced Breast Cancer, Advanced Carcinomas With Squamous Cell Histology

Breast Cancer | Metastatic Breast Cancer | Drug-Related Side Effects and Adverse Reactions | Pharmacogenetic Variant

Triple-Negative Breast Neoplasm

HER2-Positive Breast Carcinoma

Monitoring the Response of Breast Cancer to Neoadjuvant Chemotherapy Using SE and SWE

Obesity | Early-stage Breast Cancer

Breast Cancer Surgery | Post-Surgical Complication

Metastatic Breast Cancer | Positive Hormonal Receptors

Recurrent Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast Cancer AJCC v8 | Prognostic Stage IIIC Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm

Breast Carcinoma | Breast Atypical Ductal Hyperplasia | Breast Atypical Lobular Hyperplasia | Breast Lobular Carcinoma In Situ | Breast Sclerosing Adenosis

Breast Cancer

Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNB

Breast Cancer Related Lymphedema

Invasive Ductal Carcinoma, Breast

Breast Cancer Screening | Breast Cancer Screening and Diagnosis

Invasive Breast Carcinoma | Neoadjuvant Chemotherapy | Sentinel Lymph Node Biopsy (SLNB)

Breast Neoplasms | Breast Diseases | Antineoplastic Agents | Aromatase Inhibitors | Neoplasms, Breast | Hormone Receptor Positive Breast Carcinoma | ESR1 Gene Mutation

Metastatic Breast Cancer

Stage I Breast Cancer

Neoadjuvant Therapy | Cisplatin | Immunotherapy | HER2-negative Breast Cancer | Pathological Complete Response | Vinorelbine

Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation

Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer Starting a Third Line Chemotherapy

Invasive Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive

Sexual Dysfunction | Breast Cancer Female

Bone Pain | Breast Carcinoma Metastatic in the Bone

Breast Cancer | Breast Cancer Female

Breast Cancer Female

Breast Cancer Female | Genitourinary Syndrome of Menopause

Breast Cancer Invasive

Cancer of the Breast | Anomaly of Breast

Early-Stage Breast Carcinoma | Estrogen Receptor Positive Tumor

Breast Cancer Female

Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer

Obesity and Breast Cancer

Advanced Breast Cancer

Toxicity From Medication (Endocrine Treatment and Chemotherapy) Given for Breast Cancer Treatment.

Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer

Post Menopausal Women With Early Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8